Inflammatory Bowel Disease

A glance at therapeutic strategies being investigated to improve the treatment and outcomes of patients with ulcerative colitis and Crohn disease.

How to best treat a patient with inflammatory bowel disease who demonstrates no disease response to initial biologic treatment, as well as insight surrounding the treatment of patients who develop perianal disease.

Recommendations for monitoring a 24-year-old woman treated with biologic therapy to manage inflammatory bowel disease to evaluate treatment efficacy.

Factors that impact which biologic therapy a gastrointestinal specialist may initiate for a patient with inflammatory bowel disease, especially during the COVID-19 pandemic.

Recommendations when assessing response to biologic therapies used to treat ulcerative colitis and Crohn disease.

There is a lot of new information about the link between various malignancies and inflammatory bowel disease. Here: answers to 3 key questions.

Diet diaries and food frequency questionnaires are both effective tools to capture important patterns between food items and symptoms of IBD.

IDA is commonly seen in IBD as a result of iron malabsorption and, ironically, chronic blood loss through disrupted mucosal surfaces.

Patients with UC who also have celiac disease may be at higher risk for pancolitis as opposed to more limited forms of inflammatory bowel disease.

The mechanisms and effectiveness of probiotics in treatment of irritable bowel syndrome and inflammatory bowel disease are emerging.